MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung

Salgia, 2015, Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors, Cancer Discov, 5, 850, 10.1158/2159-8290.CD-15-0285

Sholl, 2016, MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression, J Clin Oncol Off J Am Soc Clin Oncol, 34, 721, 10.1200/JCO.2015.63.4600

Ladanyi, 2015, Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping, Cancer Discov, 5, 842, 10.1158/2159-8290.CD-14-1467

Borczuk, 2016, Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations, J Clin Oncol Off J Am Soc Clin Oncol, 34, 794, 10.1200/JCO.2015.62.0674

Reid, 2012, Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis, Surgery, 152, 397, 10.1016/j.surg.2012.05.007

Wislez, 2013, Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, 8, 1574, 10.1097/01.JTO.0000437008.00554.90

Antoine, 2015, High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCartaTM Panel: exploring therapeutic targets, Ann Oncol, 26, 1748, 10.1093/annonc/mdv232

Husain, 2005, Functional Expression and Mutations of c-Met and Its Therapeutic Inhibition with SU11274 and Small Interfering RNA in Non-Small Cell Lung Cancer, Cancer Res, 65, 1479, 10.1158/0008-5472.CAN-04-2650

Schwall, 2006, Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer, Cancer Res, 66, 283, 10.1158/0008-5472.CAN-05-2749

Lee, 2012, The transcriptional landscape and mutational profile of lung adenocarcinoma, Genome Res, 22, 2109, 10.1101/gr.145144.112

Zhong, 2014, Transcriptome Meta-Analysis of Lung Cancer Reveals Recurrent Aberrations in NRG1 and Hippo Pathway Genes, Nat Commun, 5, 5893, 10.1038/ncomms6893

Cadranel, 2014, Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung, Lung Cancer, 85, 276, 10.1016/j.lungcan.2014.06.004

Ross, 2016, Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations, J Thorac Oncol, 11, 1493, 10.1016/j.jtho.2016.06.004

Lemoine, 2016, Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT), Lancet Lond Engl, 387, 1415, 10.1016/S0140-6736(16)00004-0

Sobin, 2007, The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours, J Thorac Oncol, 2, 706, 10.1097/JTO.0b013e31812f3c1a

Destro, 2009, Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients, J Clin Oncol, 27, 1667, 10.1200/JCO.2008.19.1635